EN

Eswara Narayana Kosaraju

Active Director Managing Director DIN 00430474
DIN 00430474 First appointment Jun 1991 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 2 historical roles
Total affiliations 4 Since Jun 1991
Shareholding value •••• Premium profile

About Eswara Narayana Kosaraju

Data last updated:

Eswara Narayana Kosaraju is a Managing Director at Satyadeva Pharmaceuticals Private Limited (since 2000) and Managing Director at Swathi Fine Chem Private Limited (since 1993). The companies operate in Pharma, Chemicals and Materials and Manufacturing. The 2 current companies with reported revenue have a combined latest revenue of ₹103 Cr; the largest is Satyadeva Pharmaceuticals Private Limited at ₹103 Cr (FY 2025). Earlier, Eswara Narayana Kosaraju was a Director at Sourya Insulators Private Limited (2008–2015) and Managing Director at Swathi Drug Agencies Private Limited (from 1991).

DIN 00430474
Primary Designation Managing Director
Industry Pharma
First Appointment 04 Jun 1991
Oldest Company Age 35 yrs
Largest company Satyadeva Pharmaceuticals Private Limited · ₹103 Cr (FY 2025)
Combined revenue ₹103 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director11 Aug 20002000₹103 Cr (FY 2025)Active
Swathi Fine Chem Private Limited U24100TG1993PTC015886
Managing Director18 Jun 19931993₹6 Lakh (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sourya Insulators Private Limited U74900TG2008PTC061564
Director24 Oct 20082008Active
Swathi Drug Agencies Private Limited U24110TG1991PTC012763
Managing Director04 Jun 19911991Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Swathi Drug Agencies Private Limited
Satyadeva Pharmaceuticals Private Limited
Swathi Fine Chem Private Limited
Sourya Insulators Private Limited
Premium access

Shareholding and investment profile for Eswara Narayana Kosaraju

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Eswara Narayana Kosaraju

Eswara Narayana Kosaraju currently holds 2 directorships: Satyadeva Pharmaceuticals Private Limited (Managing Director, since 11 Aug 2000, revenue ₹103 Cr (FY 2025)); Swathi Fine Chem Private Limited (Managing Director, since 18 Jun 1993, revenue ₹6 Lakh (FY 2025)).

Eswara Narayana Kosaraju was first appointed on 04 Jun 1991 as Managing Director at Swathi Drug Agencies Private Limited. The most recent appointment on record is 24 Oct 2008 at Sourya Insulators Private Limited.

The 2 current companies of Eswara Narayana Kosaraju that report revenue have a combined latest revenue of ₹103 Cr: Satyadeva Pharmaceuticals Private Limited ₹103 Cr (FY 2025); Swathi Fine Chem Private Limited ₹6 Lakh (FY 2025).

Eswara Narayana Kosaraju held 2 earlier board appointments: Sourya Insulators Private Limited (Director, 24 Oct 2008 to 12 Mar 2015); Swathi Drug Agencies Private Limited (Managing Director, from 04 Jun 1991).

The current boards of Eswara Narayana Kosaraju's companies include Hari Krishna Kosaraju (Satyadeva Pharmaceuticals Private Limited), Srinivasa Rao Tubati (Satyadeva Pharmaceuticals Private Limited), Swathi Nandamuri (Satyadeva Pharmaceuticals Private Limited), Venkata Prasad Averineni (Satyadeva Pharmaceuticals Private Limited), Lakshmi Kosaraju (Swathi Fine Chem Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available